Skip to main content
. 2020 Jul 1;16(3):461–469. doi: 10.3988/jcn.2020.16.3.461

Table 3. Comparison of groups with and without recurrence in myelin oligodendrocyte glycoprotein-antibody-positive patients with acquired demyelinating syndrome.

Recurrence (n=18) No recurrence (n=28) p
Age at onset, months 104.6±45.1 84.9±48.1 0.167
Sex, males:females 6:12 15:13 0.179
Encephalopathy 4 (22) 17 (61) 0.011
Involvement site
 Brain demyelination 17 (94) 22 (79) 0.144
 Optic nerve 6 (33) 10 (36) 0.091
 Spinal cord 6 (33) 9 (32) 0.933

Data are mean±SD, n, or n (%) values.